No abstract available
MeSH terms
-
Androgen Antagonists / therapeutic use
-
Antineoplastic Agents, Hormonal / therapeutic use*
-
Clinical Trials, Phase III as Topic
-
Combined Modality Therapy / methods
-
Humans
-
Male
-
Prostatic Neoplasms / mortality
-
Prostatic Neoplasms / therapy*
-
Randomized Controlled Trials as Topic
-
Survival Analysis
Substances
-
Androgen Antagonists
-
Antineoplastic Agents, Hormonal